Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

MSD's Victrelis (boceprevir)

Hep C drug Victrelis gains EU approval

July 20, 2011 Sales and Marketing Incivek, Victrelis, hepatitis C

Merck Sharp & Dohme’s Victrelis, one of two major new hepatitis C drugs, has gained final approval in Europe. Victrelis …
News

Government seeks to salvage pharma pricing reforms

July 19, 2011 Sales and Marketing NICE, value-based pricing

The government is pushing ahead with plans to introduce value-based pricing in 2014, despite acknowledging the new system still requires …
News
Victrelis

Hepatitis C rivals go head to head

July 19, 2011 Sales and Marketing Incivek, Incivo, Victrelis, boceprevir, hepatitis C, telaprevir

 The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …
Feature
Novartis

Novartis posts double-digit sales and profit growth

July 19, 2011 Sales and Marketing Novartis

Novartis had a strong second quarter of the year, with both sales and profit up on the same period in …
News

In search of authenticity

July 19, 2011 Sales and Marketing

We don’t have a sales consultant in front of us in that situation. There is nobody to demonstrate and reassure …
Feature
Thought Leadership

NICE decides laser treatment better than Lucentis

July 18, 2011 Sales and Marketing Lucentis, NICE, Novartis

Novartis says it is “disappointed” with health watchdog NICE’s decision not to recommend Lucentis for the treatment of eye problems …
News

Amgen bone cancer drug Xgeva approved in Europe

July 18, 2011 Sales and Marketing Amgen, Prolia, Xgeva, denosumab

Amgen’s bone cancer drug Xgeva (denosumab) has been approved in Europe to prevent serious bone problems in cancer patients. Already …
News
Novartis Kick Smoking iPhone app

Digital Pharma: iPhone and iPad app update

July 15, 2011 Medical Communications, Sales and Marketing Blackberry, Digital Pharma blog, ipad, iphone, mobile

How many iPads has Boehringer Ingelheim ordered for its sales force in Turkey? Do Novartis’ investors really want their annual …
News

The changing fortunes of NICE and health secretaries

July 15, 2011 Sales and Marketing NICE

You might not have noticed, but the government has performed a major U-turn. No, I don’t mean the NHS reform …
Feature

UK pricing reform derailed

July 15, 2011 Sales and Marketing NICE, PPRS, value-based pricing

Plans to revolutionise the pricing of medicines in the UK look to be another casualty in the Department of Health’s …
News

European approval for BMS skin cancer vaccine

July 14, 2011 Sales and Marketing BMS, Yervoy, ipilimumab

Bristol-Myers Squibb’s skin cancer vaccine Yervoy has been approved in Europe after showing survival benefits in one of the most …
News

France cleans up regulation – and restricts pharma role

July 14, 2011 Research and Development, Sales and Marketing France, Mediator, Servier, pharmacovigilance, research and development news

France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …
News

Spain’s austerity sees pharma market shrink by €2 billion

July 14, 2011 Sales and Marketing Spain, healthcare costs

Spain’s pharma industry has hit out against the drastic budget cuts the government introduced last year, saying they’ve led to …
News

Market access and the new consortia

July 14, 2011 Sales and Marketing GP consortia, NHS reform, market access

The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …
Feature
Newcastle GP consortia

What now for GP consortia?

July 13, 2011 Sales and Marketing GP consortia, NHS reforms

David Cameron unveiled major changes to the direction of the health reforms on 8 June – and in doing so, …
Feature
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026